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Extracellular purines have a role in renal physiology and adaption to inflammation.
However, inflammatory renal disease may be mediated by extracellular purines, resulting
in renal injury. The role of purinergic signaling is dependent on the concentrations of
extracellular purines. Low basal levels of purines are important in normal homeostasis
and growth. Concentrations of extracellular purines are significantly elevated during
inflammation and mediate either an adaptive role or propagate local inflammation.
Adenosine signaling mediates alterations in regional renal blood flow by regulation of
the renal microcirculation, tubulo-glomerular feedback, and tubular transport of sodium
and water. Increased extracellular ATP and renal P2 receptor-mediated inflammation are
associated with various renal diseases, including hypertension, diabetic nephropathy,
and glomerulonephritis. Experimental data suggests P2 receptor deficiency or receptor
antagonism is associated with amelioration of antibody-mediated nephritis, suggesting
a pathogenic (rather than adaptive) role of purinergic signaling. We discuss the role of
extracellular nucleotides in adaptation to ischemic renal injury and in the pathogenesis of
inflammatory renal disease.
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INTRODUCTION
Purines are ubiquitous molecules that are synthesized as nucle-
osides. There are several purines with wide-ranging functions.
Adenine and guanine are purines that are essential for the synthe-
sis of DNA and RNA. Adenosine is an endogenous purine nucleo-
side that comprises a molecule of adenine linked to a ribose sugar
molecule. As a component in cyclic adenosine monophosphate
(cAMP), adenosine plays a major role in signal transduction.
Adenosine also provides energy for several intracellular biologic
reactions, with adenosine 5′-triphosphate (ATP) and ADP as
the principal energy sources. Other purines include xanthine,
hypoxanthine, and uric acid.
Among the endogenous purinergic compounds, adenosine
and ATP play a key role in the host response to inflammation
via extracellular signaling pathways. Extracellular levels of adeno-
sine and ATP are increased several-fold during inflammation,
and act on specific purinergic receptors. Activation of adenosine
receptors tends to mediate cytoprotection in response to inflam-
mation, whereas activation of the ATP-sensitive P2X7 receptor
triggers pro-inflammatory signaling. In this review, we discuss
the physiological and pathological roles of purinergic signaling
in inflammatory renal disease, with particular focus on adenosine
receptors and ATP-sensitive P2 receptors.
EXTRACELLULAR PURINES IN THE KIDNEY
Within the cytosol, ATP is present in millimolar concen-
trations (∼3–5mM in most cells). Much lower concentra-
tions of ATP are found in the extracellular environment
under basal conditions. Various physiological and pathological
conditions are associated with elevated levels of extracellular
nucleotides.
The relative contribution of different cell types to the basal
levels of extracellular nucleotides and the mechanism of purine
release is an area of active research. The most widely accepted
mechanism of release is via cell lysis- either non-specific cytolysis
of healthy cells by mechanical trauma or as a result of necrosis or
apoptosis. An alternative mechanism involves exocytotic release
of ATP and ADP via granules or vesicles that contain compart-
mentalized nucleotides. Exocytotic release of ATP via granules
is well-described in neurons and neuro- endocrine cells (von
Kugelgen et al., 1998; Bodin and Burnstock, 2001a; Fabbro et al.,
2004). Non-neuronal cells of exocrine and endocrine origin store
large amounts of ATPwithin cytosolic granules which are released
into the extracellular environment (>100mM) (Coco et al., 2003;
Obermuller et al., 2005). Extracellular release of ADP via granules
has also been described in activated platelets and immune cells
(Eltzschig et al., 2006, 2008; Weissmuller et al., 2008).
The conductive release of ATP via intrinsic plasma membrane
channels or pores in the absence of irreversible cytolysis is another
proposed mechanism of extracellular ATP release. There are vari-
ous classes of cell membrane channels associated with conductive
release of ATP. Examples include pore forming P2X7 receptors
(Ferrari et al., 1996), connexins (Kang et al., 2008) and pannexins
(Huang et al., 2007), maxi-anion channels and volume-regulated
ion channels (Hisadome et al., 2002; Bell et al., 2003, 2009).
The multiple sources of extracellular ATP have also been
described for the kidney. ATP is co-released with acetylcholine
or noradrenaline from nerve termini via synaptic vesicles within
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the kidney (Dowdall et al., 1974; Burnstock, 1995). Electrical
field stimulation of the sympathetic nerves in the renal cortex
induces release of ATP. However, this accounts for only 25%
of the total cortical ATP content, with the remainder coming
from non-neuronal sources (Vonend et al., 2002). Under basal
conditions, nanomolar concentrations of ATP are released from
proximal tubule cell primary cultures, cell lines, and in vivo
(Schwiebert, 2001; Praetorius and Leipziger, 2010). Glomeruli
have been shown to constitutively release ATP, and the macula
densa releases ATP via maxi anion channels (Bell et al., 2003,
2009; Karczewska et al., 2007). Thick ascending limb and col-
lecting duct cells have also been shown to release nanomolar
concentrations of ATP (Schwiebert, 2001). Apart from epithelial
cells, other potential sources of ATP in the kidney include cells
of the vascular network such as endothelial and smooth mus-
cle cells (Pearson and Gordon, 1979; Bodin and Burnstock, 1996,
2001b; Yamamoto et al., 2003), platelets (Detwiler and Feinman,
1973; Hechler and Gachet, 2011), mononuclear cells (Maugeri
et al., 1990), and erythrocytes (Bergfeld and Forrester, 1992;
Wan et al., 2011). The relative amounts of ATP vary within the
kidney, with ATP concentration in the proximal tubules being
4-fold greater than in Bowman’s space (Vekaria et al., 2006).
Cellular release of ATP can be induced by a range of stimuli,
including hypoxia (Bergfeld and Forrester, 1992), acute inflam-
mation (Bodin and Burnstock, 1998), fluid shear stress (Bodin
and Burnstock, 2001b), osmotic shock (Jans et al., 2002), and
mechanical deformation such as distension of the ureter (Knight
et al., 2002). Once released from cells, ATP may influence cells
in an autocrine or paracrine fashion. Extracellular ATP and
other nucleotides are rapidly hydrolyzed by membrane-bound
ecto-enzymes such as ecto-5′-nucleotidase (Dawson et al., 1989).
Therefore, P2 receptor signaling in the kidney involves a balance
between ATP release and ATP breakdown.
Basal levels of adenosine are in the range of 300 nM, but may
increase up to 4-fold during acute inflammation. Extracellular
adenosine is generated from the phosphohydrolysis of extracel-
lular ATP and ADP by constitutive ectonucleoside-triphosphate-
diphosphohydrolase-1 (CD39) and ecto-5′-nucleotidase (CD73).
CD39 catalyzes the breakdown of extracellular ATP and ADP by
rapid conversion to AMP, whereas CD73 is a membrane-bound
protein responsible for the final step in generating extracellular
adenosine by converting AMP to adenosine. Alternatively, extra-
cellular adenosine may be released by circulating cells such as
activated immune cells and platelets (Bauerle et al., 2011).
PURINOCEPTORS IN THE KIDNEY
Purinergic signaling occurs via activation of specific receptors
called purinergic receptors. Purinergic receptors can be divided
into two main families, the P1 receptors that are selective for
adenosine and the P2 receptors that are selective for ATP and
ADP. Intracellular purines are released into the extracellular space
by various mechanisms and act upon extracellular purinergic
receptors (Figure 1).
P1 RECEPTORS
The effects of extracellular adenosine are mediated via G-protein
coupled purinergic receptors. These include A1, A2A, A2B,
and A3 receptors. Adenosine receptors can be subdivided into
those that are activated by physiological levels only of adenosine
(10–100 nM) and those that require much higher levels of adeno-
sine (>1μM), as seen in pathological conditions (Fredholm,
2007). A1, A2A, and A3 receptors require physiological levels of
adenosine, whereas A3 receptors require much higher concentra-
tions of adenosine for activation. The A1 (high affinity) and A3
(low affinity) receptors mediate inhibition of the enzyme adeny-
lyl cyclase (AC) and inhibit formation of 3′, 5′-cyclic adenosine
monophosphate (cAMP), whereas the A2A (high affinity) and
A2B (low affinity) receptors stimulate AC.
The A1AR is widely expressed in the kidney, especially in the
afferent arterioles, mesangial cells, proximal convoluted tubules,
medullary collecting ducts, and papillary epithelia. The A2AAR
receptor is located predominantly in the glomerular epithelium
and adjacent vasculature (Bauerle et al., 2011). The A2BAR recep-
tors are found predominantly in the renal vasculature with min-
imal expression in renal epithelia. The precise location and role
of the A3 receptor within the kidney remains unclear. The role of
renal adenosine receptors centers primarily on regulation of renal
vascular tone and glomerular filtration rate (GFR).
P2 RECEPTORS
The P2 purinergic receptors can in turn be divided into two
subcategories: the inotropic P2X (ligand-gated ion channels)
and metabotropic P2Y receptors (G-protein-coupled receptors).
To date, seven P2X subunits (P2X1-7) and eight P2Y subunits
(P2Y1,2,4,6,11–14) have been identified. The effect of extracel-
lular ATP on renal epithelial cells was first reported in 1972, when
ATP was shown to increase calcium release from a suspension of
cortical tubules (Rorive and Kleinzeller, 1972). ATP is now known
to exert its effects via distinct P2 receptors. P2 receptor mRNA
and protein are expressed throughout the nephron, vasculature,
and interstitial cells (Bailey et al., 2000, 2001; Turner et al., 2003).
Differential basolateral and apical cell membrane expression of
P2 receptors has been reported (Bailey et al., 2000, 2001; Deetjen
et al., 2000; Kishore et al., 2000; Turner et al., 2003). The roles
postulated for P2 receptors in the kidney are multiple and diverse,
including cell cycle regulation, mediators of hormonal control in
the proximal tubule, mediators or moderators of TGF, and reg-
ulators of ion transport processes along the nephron. Numerous
studies have shown that ATP contributes to many pathophysio-
logical processes, including cell proliferation, apoptosis, vascular
remodeling, inflammation and necrosis.
One of the key purinoceptors in promoting inflammation
is the P2X7 receptor (P2X7R). Expression of this receptor was
originally defined in macrophages and monocytes (Di Virgilio
et al., 2001), and has since been characterized in several differ-
ent cell types, including intrinsic renal cells (Arulkumaran et al.,
2011). Unlike other P2X receptors the P2X7 receptor is distinct,
because its downstream signaling is coupled to pro- inflamma-
tory cascades (North, 2002). Cell damage and death during active
inflammation results in an increase in local concentrations of
extracellular ATP. Activation of the P2X7R in vitro requires extra-
cellular concentrations of ATP in the range of 1mM, in contrast
to concentrations<100μMneeded to activate other P2 receptors.
Therefore, the P2X7 receptor is thought to act as a “danger signal”
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FIGURE 1 | Intracellular purines are released into the extracellular space by various mechanisms and act upon extracellular purinergic receptors.
in response to damaged or lysed cells. Transient activation of the
P2X7R leads to release of the pro-inflammatory cytokines IL-1β
and IL-18. Prolonged activation of P2X7R results in irreversible
pore formation and allows the non-selective passage of ions and
hydrophilic solutes of up to 900 Da, which can result in colloido-
osmotic lysis and cell death by apoptosis or necrosis (Ferrari et al.,
2006).
PURINES AND CELL SURVIVAL
P2 purinoceptos have been shown to regulate cell survival and
death. The precise functional effect of purinoceptors on cell sur-
vival is very much dependent on the local environment. Studies
measuring the incorporation of 3H-thymidine into the cellular
DNA of mesangial cells after agonist stimulation of P2 recep-
tors have demonstrated that extracellular nucleotides can regulate
mesangial cell proliferation in vitro via P2Y receptor activation
(Schulze-Lohoff et al., 1992; Huwiler and Pfeilschifter, 1994;
Ishikawa et al., 1994; Harada et al., 2000). More recently, ATP-
induced proliferation of mesangial cells was shown to be through
P2Y receptor activation of the MAPK42/44 signal transduction
pathway (Vonend et al., 2003). Extracellular nucleotides may also
activate the stress-activated protein kinase (SAPK) and the p38-
stress-activated protein kinase (MAPK38) cascades in mesangial
cells via P2Y receptors (Huwiler et al., 1997, 2000). These cascades
are most often activated by cellular stresses such as chemicals,
heat, osmotic shock, and UV irradiation (Paul et al., 1997). The
balance between nucleotide-stimulation of the MAPK42/44 path-
way (Vonend et al., 2003), the SAPK and MAPK38 pathways,
determines whether cells survive or undergo apoptosis (Huwiler
et al., 1997, 2000). Cultured mesangial cells have been shown
to undergo apoptosis via stimulation of the P2X7R by ATP and
inhibited by P2X7 receptor antagonists (Schulze-Lohoff et al.,
1998). The trigger for apoptosis has most often been associated
with P2X7R activity (Schulze-Lohoff et al., 1998; Bulanova et al.,
2005; Turner et al., 2007; Taylor et al., 2009; Kawano et al., 2012)
although P2X4R-mediated apoptosis has been reported in cul-
tured human mesangial cells and in a mouse macrophage cell line
(Kawano et al., 2012; Solini et al., 2007).
Interestingly a proliferative role has also been suggested for the
P2X7 receptor in non-renal cells. P2X7 transfected HEK293 cells
exhibited enhanced tumorigenesis when inoculated into immun-
odeficient BALB/c mice (Adinolfi et al., 2012); moreover, P2X7R
expression has been reported to be upregulated in malignant
tumor cells (Di Virgilio et al., 2009).
INFLAMMATORY RENAL DISEASES
RENAL ISCHEMIA
During global hypoxia or impaired renal perfusion, ATP con-
sumption exceeds ATP production. This results in elevated
adenosine levels (Miller et al., 1978; Beach et al., 1991; Nishiyama
et al., 1999). This may be seen in a number of acute clinical
scenarios, including hemorrhage and endotoxaemia. Adenosine
signaling mediates alterations in regional renal blood flow,
preserving bioenergetics and cellular structure (Weinberg and
Venkatachalam, 2012).
Tubulo-glomerular feedback (TGF) is a negative feedback
mechanism whereby changes in luminal NaCl delivery and reab-
sorption at the macula densa can adjust the vascular tone of
the afferent arteriole to alter and match glomerular filtration
(Schnermann et al., 1973). TGF allows each nephron to reg-
ulate its GFR in accordance with the capacity of its proximal
tubule to reabsorb NaCl. Extracellular adenosine contributes to
www.frontiersin.org July 2013 | Volume 4 | Article 194 | 3
Arulkumaran et al. Purines and renal inflammation
the regulation of GFR. Renal interstitial adenosine is mainly
derived from dephosphorylation of released ATP, AMP, or cAMP
by the enzyme ecto-5′-nucleotidase (CD73) (Le Hir and Kaissling,
1993). This enzyme catalyzes the dephosphorylation of 5′-AMP
or 5′-IMP to adenosine or inosine, respectively, and is located
primarily on the external membranes and mitochondria of proxi-
mal tubule cells, but not in distal tubule or collecting duct cells
(Miller et al., 1978). ATP consumed in active transport by the
macula densa also contributes to the formation of adenosine by
5- nucleotidase (Thomson et al., 2000). Extracellular adenosine
activates A1 receptors on vascular afferent arteriolar smooth mus-
cle cells, resulting in vasoconstriction and a reduction in GFR
(Schnermann et al., 1990). Renal clearance and micropuncture
experiments in CD73 null mice demonstrate a diminished TGF
response to increasing proximal tubule perfusion (Huang et al.,
2006). These effects of extracellular adenosine are mediated via
A1 receptors, since blockade of these receptors completely abro-
gates TGF, and mice deficient in adenosine A1 receptors also
lack a normal TGF response (Vallon et al., 2004). P2X1 receptors
autoregulate renal blood flow when juxtamedullary afferent arte-
riolar pressure is elevated. Activation of P2X1 receptors on pre-
glomerular arteriolar smooth muscle cells results in an increase
in intracellular Ca2+ concentration, leading to vasoconstriction.
This response is blunted in hypertensive (Angiotensin II treated,
high- salt diet) rats, suggesting that P2X1 receptors are important
for pressure-mediated autoregulatory responses (Inscho et al.,
2011).
Elevated extracellular concentrations of adenosine within the
kidney are seen in local ischemia (Miller et al., 1978; Beach
et al., 1991; Nishiyama et al., 1999). During ischemia, aerobic
metabolism and ATP production are impaired. This limits the
ability of the proximal tubule to reabsorb filtered electrolytes
and water, a highly energy-dependent process. Elevated adenosine
levels may limit GFR via TGF, reducing the need for tubular reab-
sorption and preserving renal bioenergetics. Experimental work
demonstrates that generation of adenosine by renal CD73 during
renal ischemia, and selective renal A1 receptor agonists protect
against renal ischemia and reperfusion injury (Park et al., 2012;
Kim et al., 2013).
Renal concentrations of adenosine are elevated in response
to endotoxic shock (Miller et al., 1978; Beach et al., 1991;
Nishiyama et al., 1999). In an experimental model of endotox-
aemia and shock, reduced mean arterial pressure and renal blood
flow were associated with an elevated renal adenosine concen-
tration. Antagonism of the A1 receptor attenuated the reduction
in mean arterial pressure and renal blood flow, suggesting that
adenosine may preserve renal blood flow during endotoxic shock
(Nishiyama et al., 1999).
Selective augmentation of adenosine around afferent arterioles
causes persistent vasoconstriction, indicating A1AR dominance.
In contrast to the A1AR-receptor, the A2AAR-receptor mediates
vasodilatation in deep cortical glomerular vessels, and increases
medullary blood flow and oxygenation (Vallon and Osswald,
2009). Global elevation of renal adenosine causes steady-state
vasodilatation from A2AR-mediated generation of nitric oxide
(Hansen et al., 2005). Thus, global increments in adenosine pro-
duction and release may increase total blood flow through A2AR
generation of NO, while allowing a compensatory reduction in
tubular workload by a reduction in A1AR activation. This can
maintain renal oxygenation, while at the same time limiting renal
workload. Adenosine protects from ischemic acute kidney injury
(AKI) in a mouse model of ischemia -reperfusion by preserving
peritubular capillary blood flow during reperfusion via activation
of A2AR on endothelial cells (Grenz et al., 2012).
VASCULAR REMODELING AND HYPERTENSION
Immunohistochemistry has shown that P2X1, P2X2, P2X7 and
P2Y1 receptors are expressed on the renal vasculature (Lewis and
Evans, 2001; Turner et al., 2003) and are responsible for the reg-
ulation of renal hemodynamics (reviewed in Guan et al., 2007).
Stimulated endothelial cells release endogenous nucleotides and
changes in renal arterial pressure result in increased intersti-
tial ATP concentration (Yegutkin et al., 2000; Nishiyama et al.,
2001). Studies indicate that alteration in ATP/P2 receptor sig-
naling may result in renal vascular dysfunction and may lead
to hypertension. Angiotensin II mediates hypertension by pro-
moting mesangial cell transformation, renal inflammation, and
vascular hypertrophy. Mice deficient in P2X1 receptors or treated
with the non-specific P2 receptor antagonist PPADS, or a spe-
cific P2Y12 receptor antagonist, demonstrate an attenuation of
angiotensin II-mediated hypertension (Graciano et al., 2008;
Franco et al., 2011). This suggests that angiotensin II mediates
hypertension via its action on vascular and glomerular P2 recep-
tors. P2Y2 and P2Y4 receptors regulate ENaC activity in the
collecting duct, thereby regulating sodium balance and systemic
hypertension (Wildman et al., 2008). Glomerular hypertension
results in glomerular capillary wall stretch, endothelial damage,
and a rise in protein glomerular filtration, leading to further
ATP release (Bodin and Burnstock, 1998; Yegutkin et al., 2000;
Nishiyama et al., 2001; Schwiebert, 2001). This autocrine loop of
released ATP and cell stimulation exacerbates the inflammatory
response by further release of inflammatory cytokines, as sup-
ported by a rat model of renin-dependent hypertension in which
glomerular P2X7R was up-regulated at 12 weeks (Vonend et al.,
2004). The P2X4 receptor has also been shown to regulate vascu-
lar remodeling. Local ATP released during increased renal blood
flow acts upon endothelial P2X4 receptors, resulting in calcium
influx and the production of nitric oxide. This effect is attenuated
in P2X4-deficient mice, and, P2X4-deficient mice fail to exhibit
adaptive vascular remodeling in response to a chronic decrease in
renal blood flow (Yamamoto et al., 2006).
ANTIBODYMEDIATED RENAL DISEASE
Increased glomerular P2X7R expression has been reported in a
mouse model of accelerated nephrotoxic nephritis, with P2X7R
expression coinciding with an increase in apoptotic cells (Turner
et al., 2007). Similarly, in a rat model of antibody-mediated
glomerulonephritis increased P2X7R mRNA expression coin-
cided with the onset of proteinuria and an increase in IL-1β
and pro-apoptotic genes (Turner et al., 2007). P2X7R is also
upregulated in patients with lupus nephritis. Genetic deletion of
P2X7R is associated with amelioration of renal injury in a murine
model of antibody-mediated glomerulonephritis, with reduced
macrophage infiltration, less fibrin deposition, less glomerular
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thrombosis, reduced thrombosis and overall protection of renal
function. This coincides with a reduction in the chemokine
CCL2 in P2X−/−7 mice compared with wildtype controls (Taylor
et al., 2009). Similarly the P2X7R antagonist A438079 reduces
the severity of antibody-mediated glomerulonephritis in rats with
reduced proteinuria and renal macrophage infiltration (Taylor
et al., 2009). In a model of passive crescentic glomerulonephritis,
P2Y1 gene deficiency was also renoprotective, reducing capil-
lary loss, fibrosis, and death by renal failure (Hohenstein et al.,
2007). The current evidence are based on models induced by
passive injection of glomerular binding antibodies. The roles of
purinergic receptors in antigen presentation and development of
autoimmune response need to be investigated.
DIABETIC KIDNEY DISEASE
Significant glomerular expression of P2X7R is reported in rats
with steptozotocin-induced diabetes with a corresponding 10-
fold increase in P2X7R mRNA expression (Vonend et al., 2004).
Electron microscopy demonstrated that P2X7R was located pri-
marily on podocytes and endothelial cells. Both oxygen and
glucose deprivation have been shown to increase integration of
P2X7R into the cell membrane of HEK 293 cells (Milius et al.,
2007). Culturing cells in high glucose-containing media stimu-
lated ATP secretion in rat mesangial cells, but with no change in
P2 receptor expression (Solini et al., 2005). High glucose has also
been shown to initiate inflammasome activation through P2X4R
regulation in HK-2 cells (Chen et al., 2013). In type 2 diabetic
patients with nephropathy, tubular P2X4R expression was upreg-
ulated and closely related to NLRP3 inflammasome activation
and renal interstitial inflammation (Chen et al., 2013). The func-
tional importance of purinergic receptors in diabetic nephropathy
still require further investigation in vivo, and in clinical studies.
URETERIC OBSTRUCTION
The role of P2X7R and TGF-β in extracellular matrix deposi-
tion was demonstrated in a mouse model of unilateral ureteral
obstruction (UUO) (Goncalves et al., 2006). Myofibroblast
number and collagen deposition were significantly reduced in
P2X7R KO mouse compared with wildtype mice in a UUO
model. Immunohistochemistry demonstrated significantly less
Myofibroblasts and Sirius-red staining in KO mice on day 7 with
a reduction in TGF-β. Furthermore, at day 14, there were reduced
numbers of infiltrating macrophages associated with less tubular
cell apoptosis in kidneys from the P2X7R KO mice. The tubulo-
interstitial damage and subsequent fibrosis at this time point were
attenuated in P2X7R KO mice, again implicating tubular P2X7R
in renal inflammation and fibrosis.
CONCLUSION
Purines play a key role in maintaining renal physiology during
health and mediate adaptation to pathologic conditions, includ-
ing ischemia and endotoxaemia. P2 purinoreceptors are “danger
sensors” and are key players in inflammation. However, in cer-
tain circumstances, inflammation mediated via P2 receptors may
become pathological, leading to tissue damage and renal injury.
The potential role of selective antagonists against purinoreceptors
as a therapeutic target in pro-inflammatory renal diseases, includ-
ing glomerulonephritis and diabetes requires further evaluation.
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